SHP2: A Redox-Sensitive Regulator Linking Immune Checkpoint Inhibitor Therapy to Cancer Treatment and Vascular Risk. - López Moreno SF; Lenz SA; Casso-Chapa B; Paniagua-Bojorges A; Kim JH; Palaskas NL; Nead KT; Samanthapudi VSK; Mejia G; Hoang O; Lee J; Lin SH; et al. (Antioxidants (Basel, Switzerland), 2025)